Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey

QR Code

Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey

Monica Varano,1 Nicole Eter,2 Steve Winyard,3 Kim U Wittrup-Jensen,4 Rafael Navarro,5 Julie Heraghty6On behalf of the wAMD Patient and Caregiver Survey Committee members1Department of Ophthalmology, Fondazione GB Bietti-IRCCS, Rome, Italy; 2Department of Ophthalmology, University of Münster...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Varano M, Eter N, Winyard S, Wittrup-Jensen KU, Navarro R, Heraghty J
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2015
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/dbb8d06aa46e4226b36e810d3a8ced42
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
par: Varano M, et autres
Publié: (2016)

Epimacular brachytherapy for wet AMD: current perspectives
par: Casaroli-Marano RP, et autres
Publié: (2014)

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
par: Otsuji T, et autres
Publié: (2013)

Spatio-temporal alterations in retinal and choroidal layers in the progression of age-related macular degeneration (AMD) in optical coherence tomography
par: Wolf-Dieter Vogl, et autres
Publié: (2021)

Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8)
par: Horner F, et autres
Publié: (2019)

Trends in Real-World Neovascular AMD Treatment Outcomes in the UK
par: Mehta H, et autres
Publié: (2020)

LIFE-CYCLE HYPOTHESIS AMD THE INFLUENCE OF FISHER’S INTERTEMPORAL APPROACH
par: masyhudi muqorobin
Publié: (2010)

Factors affecting the use of antioxidant supplements in patients with late AMD
par: Yu AL, et autres
Publié: (2014)

Reproductive health and rights: HIV/AIDS amd gender equality
Publié: (2015)

The impact of vascular risk factors on the thickness and volume of the choroid in AMD patients
par: Elżbieta Krytkowska, et autres
Publié: (2021)

Therapeutic Potential of the Ranibizumab Port Delivery System in the Treatment of AMD: Evidence to Date
par: Chen ER, et autres
Publié: (2020)

Prevalence and new onset of depression and anxiety among participants with AMD in a European cohort
par: Jasmin Rezapour, et autres
Publié: (2020)

Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients
par: Ehlken C, et autres
Publié: (2017)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
par: Chaikin L, et autres
Publié: (2015)

Selective retina therapy and thermal stimulation of the retina: different regenerative properties - implications for AMD therapy
par: Elisabeth Richert, et autres
Publié: (2021)

AMD3100 inhibits the migration and differentiation of neural stem cells after spinal cord injury
par: Jia-Ming Liu, et autres
Publié: (2017)

RNA editing of the AMD1 gene is important for ascus maturation and ascospore discharge in Fusarium graminearum
par: Shulin Cao, et autres
Publié: (2017)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
par: Dervenis N, et autres
Publié: (2016)

Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
par: Iida T, et autres
Publié: (2016)

ANÁLISIS DE LA FRACCCIÓN LIPÍDICA DE LA YEMA DE HUEVOS POR AMD-HPTLC
par: Figueroa,Carolina E., et autres
Publié: (2002)

Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
par: Keles S, et autres
Publié: (2014)

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
par: Neffendorf JE, et autres
Publié: (2015)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
par: Dervenis N, et autres
Publié: (2016)

Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
par: Pamela Piscitelli, et autres
Publié: (2017)

Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease
par: Enrico Borrelli, et autres
Publié: (2020)

Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration
par: Suetsugu T, et autres
Publié: (2016)

Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study
par: Asahi MG, et autres
Publié: (2020)

Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections
par: Strzalka-Mrozik B, et autres
Publié: (2017)

Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin&reg;) for AMD followed by controlateral sympathetic ophthalmia
par: Dimitrios Brouzas, et autres
Publié: (2009)

Treatment of AMD using a combination of saw dust, bentonite clay and phosphate in the removal of turbid materials and toxic metals
par: I. O. Ntwampe
Publié: (2021)

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
par: Patel PJ, et autres
Publié: (2017)

Extracellular vesicles released by human retinal pigment epithelium mediate increased polarised secretion of drusen proteins in response to AMD stressors
par: Miguel Flores‐Bellver, et autres
Publié: (2021)

Effect of carbon source and metal toxicity for potential acid mine drainage (AMD) treatment with an anaerobic sludge using sulfate-reduction
par: C. D. Loreto, et autres
Publié: (2021)

Patients&rsquo; knowledge and perspectives on wet age-related macular degeneration and its treatment
par: Sushma Kandula, et autres
Publié: (2010)

Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
par: Stewart MW
Publié: (2012)

Spectral domain OCT versus time domain OCT in the evaluation of macular features related to wet age-related macular degeneration
par: Isola V, et autres
Publié: (2012)

A Novel Method of Mouse RPE Explant Culture and Effective Introduction of Transgenes Using Adenoviral Transduction for <i>In Vitro</i> Studies in AMD
par: Peng Shang, et autres
Publié: (2021)

Amyloid β peptides overexpression in retinal pigment epithelial cells via AAV-mediated gene transfer mimics AMD-like pathology in mice
par: Tuhina Prasad, et autres
Publié: (2017)

CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation
par: Ullah A, et autres
Publié: (2019)

The removal of turbidity and toxic metals in the AMD using a combination of saw dust, bentonite clay and synthetic CaMg.2(OH)2
par: I. O. Ntwampe
Publié: (2021)